Welcome to CDC Stacks | The Costly burden of drug-resistant TB in the United States - 22071 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The Costly burden of drug-resistant TB in the United States
  • Published Date:
    March 2014
  • Language:
    English
Filetype[PDF - 1.88 MB]


Details:
  • Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
  • Keywords:
  • Description:
    Multidrug-resistant (MDR) tuberculosis is a major health threat globally. Nearly half a million MDR TB cases are estimated to occur worldwide annually, including cases that are extensively drug-resistant (XDR). This infographic highlights that while MDR and XDR TB are relatively rare in the U.S., their treatment comes at a terrible price – it is very expensive, takes a long time to treat, disrupts lives, and has potentially life-threatening side effects.

  • Document Type:
    Poster
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. The Costly burden of drug-resistant TB in the United States
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
    Published:
    October 2016
    Description:
    Multidrug-resistant (MDR) tuberculosis is a major health threat globally. Nearly half a million MDR TB1 cases are estimated to occur worldwide annually, including cases that are extensively drug-resistant (XDR).2 : While MDR and XDR TB are relatively...
    File Type:
    Filetype[PDF - 2.13 MB]
  2. The Urgent threat of TB drug resistance : drug resistant TB threatens to erase decades of progress
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    August 2016
    Description:
    One-third of the world’s population is infected with TB, and 10.4 million people become sick with active TB disease each year. TB is among the leading causes of death from infectious disease globally and claims 1.8 million lives each year, even tho...
    File Type:
    Filetype[PDF - 601.78 KB]
  3. The Urgent threat of TB drug resistance : drug resistant TB threatens to erase decades of progress
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    March 2017
    Description:
    One-fourth of the world’s population is infected with TB, and 10.4 million people become sick with active TB disease each year. TB is among the leading causes of death from infectious disease globally and claims 1.8 million lives each year, even th...
    File Type:
    Filetype[PDF - 611.33 KB]
  4. Estimating the Burden of Chagas Disease in the United States
    Personal Author:
    Manne-Goehler, Jennifer; Umeh, Chukwuemeka A.; Montgomery, Susan P.; Wirtz, Veronika J.;
    Published:
    Nov 07 2016
    Source:
    PLoS Negl Trop Dis. 10(11).
    Description:
    Background : In recent years, there has been growing awareness of the significant burden of Chagas disease in the United States (US). However, epidemiological data on both prevalence and access to care for this disease are limited. The objective of t...
    File Type:
    Filetype[PDF - 1.14 MB]
  5. In Reply to ‘The Myth of the Future Burden of CKD in United States’
    Personal Author:
    Hoerger, Thomas J.; Burrows, Nilka Ríos; Pavkov, Meda E.;
    Published:
    Jul 2015
    Source:
    Am J Kidney Dis. 66(1):172.
    File Type:
    Filetype[PDF - 32.36 KB]